We are live on ! Find out more
TC

TradeLink Capital Portfolio holdings

AUM $13.2M
1-Year Est. Return 33.27%
This Quarter Est. Return
+5.52%
1 Year Est. Return
+33.27%
3 Year Est. Return
+48.31%
5 Year Est. Return
+69.64%
10 Year Est. Return
+1,512.66%
AUM
$69.2M
AUM Growth
-$5.99M
Cap. Flow
-$8.57M
Cap. Flow %
-12.38%
Top 10 Hldgs %
41.3%
Holding
323
New
150
Increased
5
Reduced
12
Closed
94

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.09%
2 Technology 18.63%
3 Industrials 11.02%
4 Energy 7.2%
5 Healthcare 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BALT
201
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$20K 0.03%
+3,200
New +$20.3K
QUIK icon
202
QuickLogic
QUIK
$211M
$19K 0.03%
+257
New +$17.3K
TVTX icon
203
Travere Therapeutics
TVTX
$5.17B
$19K 0.03%
+900
New +$13.8K
OCLR
204
DELISTED
Oclaro Inc.
OCLR
$19K 0.03%
+6,100
New +$17.1K
GALT icon
205
Galectin Therapeutics
GALT
$230M
$18K 0.03%
+1,200
New +$17.1K
IBCP icon
206
Independent Bank Corp
IBCP
$796M
$18K 0.03%
+1,400
New +$18.2K
REI icon
207
Ring Energy
REI
$307M
$18K 0.03%
+1,200
New +$16.7K
ABR icon
208
Arbor Realty Trust
ABR
$977M
$17K 0.02%
+2,500
New +$17.1K
HRTX icon
209
Heron Therapeutics
HRTX
$93.4M
$17K 0.02%
+1,200
New +$16K
ACGN
210
DELISTED
Aceragen Inc
ACGN
$17K 0.02%
+31
New +$21.2K
TA
211
DELISTED
TravelCenters of America LLC
TA
$17K 0.02%
+420
New +$18.3K
ACIC icon
212
American Coastal Insurance
ACIC
$536M
$16K 0.02%
+1,100
New +$15.2K
ALTO icon
213
Alto Ingredients
ALTO
$338M
$16K 0.02%
+1,000
New +$10.1K
CLFD icon
214
Clearfield
CLFD
$401M
$16K 0.02%
+700
New +$15.6K
BEAT
215
DELISTED
BioTelemetry, Inc.
BEAT
$15K 0.02%
+1,500
New +$13.8K
LEE icon
216
Lee Enterprises
LEE
$175M
$14K 0.02%
+320
New +$14.3K
NSTG
217
DELISTED
NanoString Technologies, Inc.
NSTG
$14K 0.02%
+700
New +$13.3K
DWCH
218
DELISTED
Datawatch Corp
DWCH
$14K 0.02%
+500
New +$15.4K
ANIP icon
219
ANI Pharmaceuticals
ANIP
$1.86B
$13K 0.02%
+400
New +$10.6K
TBRA
220
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$13K 0.02%
+111
New +$7.79K
NWBO
221
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$13K 0.02%
+1,800
New +$10.7K
NBSE
222
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$12K 0.02%
+2
New +$10.5K
SRNE
223
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$12K 0.02%
+900
New +$9.96K
HNSN
224
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$11K 0.02%
+410
New +$9.2K
TSRE
225
DELISTED
TRADE STREET RESIDENTIAL, INC. COMMON STOCK
TSRE
$11K 0.02%
+1,500
New +$11K

Similar funds

TradeLink Capital's Q1 2014 Portfolio in Review

As of Q1 2014, TradeLink Capital held 323 positions worth $69.2M, down 8% from $75.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

TradeLink Capital withdrew a net $8.57M in Q1 2014, closing 94 positions and reducing 12 holdings. Its most notable exit was RenaissanceRe, an estimated $2.48M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, TradeLink Capital opened a new position in Las Vegas Sands worth $10.2M.

  • TradeLink Capital's largest Q1 2014 buy was Las Vegas Sands: 126,100 shares worth $10.2M.
  • TradeLink Capital added most to IBM in Q1 2014, an estimated $1.5M increase.
  • TradeLink Capital's biggest Q1 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.28M.
  • TradeLink Capital fully exited RenaissanceRe in Q1 2014, selling an estimated $2.48M.
  • TradeLink Capital's ten largest holdings make up 41% of its $69.2M portfolio in Q1 2014.
  • TradeLink Capital opened 150 new positions and closed 94 in Q1 2014.
  • TradeLink Capital's portfolio value fell 8% quarter-over-quarter to $69.2M.

Based on TradeLink Capital's 13F filing for Q1 2014, filed 9 May 2014.